Hepatitis C is a viral infection that causes inflammation of the liver. Genotypes are used to identify particular strains of HCV which are based upon differences in particular regions of the viral genome. Hepcinat-LP is a prescription medicine containing Ledipasvir (90mg) a viral NS5A inhibitor and Sofosbuvir (400mg) a nucleotide inhibitor of the viral RNA polymerase.
The international brand name of this medicine is Harvoni that provides effective treatment in Hepatitis C Genotype 1 with a cure rate ranging between 94% to 99%. Hepcinat-LP helps prevent Hepatitis C Virus infection from multiplying in your body by weakening the virus and inhibiting its reproduction and replication.
How HEPCINAT-LP TABLET works
Ledipasvir works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time.
Side effects :-
The following is a list of possible side-effects that may occur from all constituting ingredients of HEPCINAT-LP TABLET. This is not a comprehensive list. These side-effects are possible, but do not always occur.
- Headache 2. Tired feeling. 3. Lower back pain.
Name: HEPCINAT-LP Tablets
Active Ingredients: Hepcinat LP contains Ledapasvir 90 MG and Sofosbivir 400 Mg.
Dosage Form: Tablets in bottle.
Retail Pack: Pack of 28 Tablets
Company Name: NATCO PHARMA LTD
Item Code: HEPCINATLP
Minimum Order Quantity: 1 Bottle(s)